期刊论文

中文

中华危重病急救医学

2095-4352

2022

34

7

732-735

10.3760/cma.j.cn121430-20220523-00507

湖南省自然科学基金（2022JJ30545）； 湖南省科技创新计划项目（2020SKC2009）；

本校为第一机构

目的:探讨血清激活素A（ACT-A）水平用于早期识别中重症急性胰腺炎（AP）的临床价值。方法:采用前瞻性病例对照研究方法，招募2020年10月至2022年4月南华大学衡阳医学院附属南华医院肝胆外科收治的120例AP患者作为观察对象，依据修订后的亚特兰大分级对所有观察对象进行病情分级，分为轻症AP组和中重症AP组。抽取患者入院24 h内的血液标本，采用酶联免疫吸附试验（ELISA）检测血清ACT-A和C-反应蛋白（CRP）水平，并进行Ranson评分和改良CT严重指数（MCTSI）评分。采用Pearson相关法分析各项参数的相关性；绘制受试者工作特征曲线（ROC曲线），分析ACT-A和CRP对中重症AP的预测价值。结果:120例AP...

Objective:To explore the value of serum activin A (ACT-A) level in early identification of moderate and severe acute pancreatitis (AP).Methods:A prospective case control study was conducted. A total of 120 patients with AP admitted to department of hepatobiliary surgery of Affiliated Nanhua Hospital of Hengyang Medical College of University of South China between October 2020 and April 2022 were recruited. According to the revised Atlanta classification, all patients were classified into mild AP group and moderate-to-severe AP group. The blood ...